BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 28917272)

  • 1. Towards personalized medicine of colorectal cancer.
    Aziz MA; Yousef Z; Saleh AM; Mohammad S; Al Knawy B
    Crit Rev Oncol Hematol; 2017 Oct; 118():70-78. PubMed ID: 28917272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precision medicine in colorectal cancer: Leveraging multi-omics, spatial omics, and artificial intelligence.
    Xu Z; Li W; Dong X; Chen Y; Zhang D; Wang J; Zhou L; He G
    Clin Chim Acta; 2024 Jun; 559():119686. PubMed ID: 38663471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omics technologies for improved diagnosis and treatment of colorectal cancer: Technical advancement and major perspectives.
    Dalal N; Jalandra R; Sharma M; Prakash H; Makharia GK; Solanki PR; Singh R; Kumar A
    Biomed Pharmacother; 2020 Nov; 131():110648. PubMed ID: 33152902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From Omic Layers to Personalized Medicine in Colorectal Cancer: The Road Ahead.
    Romero-Garmendia I; Garcia-Etxebarria K
    Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
    Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized treatment for colorectal cancer: novel developments and putative therapeutic strategies.
    Akkad J; Bochum S; Martens UM
    Langenbecks Arch Surg; 2015 Feb; 400(2):129-43. PubMed ID: 25701352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in colorectal cancer genomics and transcriptomics drive early detection and prevention.
    Lam KK; Thean LF; Cheah PY
    Int J Biochem Cell Biol; 2021 Aug; 137():106032. PubMed ID: 34182137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
    Ma H; Chen G; Guo M
    Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions.
    Mohapatra SS; Batra SK; Bharadwaj S; Bouvet M; Cosman B; Goel A; Jogunoori W; Kelley MJ; Mishra L; Mishra B; Mohapatra S; Patel B; Pisegna JR; Raufman JP; Rao S; Roy H; Scheuner M; Singh S; Vidyarthi G; White J
    Dig Dis Sci; 2018 May; 63(5):1123-1138. PubMed ID: 29572615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics, genomics, and molecular biology in the personalized treatment of colorectal cancer.
    Carethers JM
    J Gastrointest Surg; 2012 Sep; 16(9):1648-50. PubMed ID: 22760966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying N-Glycan Biomarkers in Colorectal Cancer by Mass Spectrometry.
    Sethi MK; Hancock WS; Fanayan S
    Acc Chem Res; 2016 Oct; 49(10):2099-2106. PubMed ID: 27653471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Personalized medicine--the future is already here].
    Abadi-Korek I; Shemer J
    Harefuah; 2011 May; 150(5):451-2, 490. PubMed ID: 21678641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalizing therapy for colorectal cancer.
    Wong A; Ma BB
    Clin Gastroenterol Hepatol; 2014 Jan; 12(1):139-44. PubMed ID: 24025538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individualized therapy for metastatic colorectal cancer.
    Silvestri A; Pin E; Huijbers A; Pellicani R; Parasido EM; Pierobon M; Petricoin E; Liotta L; Belluco C
    J Intern Med; 2013 Jul; 274(1):1-24. PubMed ID: 23527888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision Nutrition for Targeting Lipid Metabolism in Colorectal Cancer.
    Aguirre-Portolés C; Fernández LP; Ramírez de Molina A
    Nutrients; 2017 Sep; 9(10):. PubMed ID: 28956850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From tumour heterogeneity to advances in precision treatment of colorectal cancer.
    Punt CJ; Koopman M; Vermeulen L
    Nat Rev Clin Oncol; 2017 Apr; 14(4):235-246. PubMed ID: 27922044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular markers in the treatment of metastatic colorectal cancer.
    Wilson PM; Labonte MJ; Lenz HJ
    Cancer J; 2010; 16(3):262-72. PubMed ID: 20526105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Omics" in pharmaceutical research: overview, applications, challenges, and future perspectives.
    Yan SK; Liu RH; Jin HZ; Liu XR; Ye J; Shan L; Zhang WD
    Chin J Nat Med; 2015 Jan; 13(1):3-21. PubMed ID: 25660284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities.
    Wang W; Kandimalla R; Huang H; Zhu L; Li Y; Gao F; Goel A; Wang X
    Semin Cancer Biol; 2019 Apr; 55():37-52. PubMed ID: 29775690
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.